Trials / Conditions / Pediatric Solid Tumor

Pediatric Solid Tumor

23 registered clinical trials studyying Pediatric Solid Tumor — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	B7-H3.CD28Z.CART in Solid Tumors NCT07358260	Robbie Majzner	Phase 1
Recruiting	Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhi NCT05521984	Washington University School of Medicine	Phase 1
Recruiting	Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Pat NCT05468359	St. Jude Children's Research Hospital	Phase 1 / Phase 2
Active Not Recruiting	Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children NCT05620862	Sun Yat-sen University	Phase 1
Recruiting	B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3 NCT04897321	St. Jude Children's Research Hospital	Phase 1
Unknown	Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy NCT05322187	RenJi Hospital	Phase 2 / Phase 3
Recruiting	UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumo NCT06760117	Sun Yat-sen University	Phase 1
Recruiting	Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents NCT05151718	Institut Claudius Regaud	—
Completed	A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor NCT05024331	Samsung Medical Center	—
Recruiting	Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT04483778	Seattle Children's Hospital	Phase 1
Terminated	GVAX Plus Checkpoint Blockade in Neuroblastoma NCT04239040	Dana-Farber Cancer Institute	Phase 1
Active Not Recruiting	EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT03618381	Seattle Children's Hospital	Phase 1
Completed	Effects of Music and Maternal Voice on Sedation Depth and Sedative Use During Pediatric Magnetic Resonance Ima NCT04944875	TC Erciyes University	N/A
Active Not Recruiting	Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and NCT03478462	Cellectar Biosciences, Inc.	Phase 1
Recruiting	Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors NCT03739827	National Cancer Institute (NCI)	—
Completed	A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) NCT03455140	University of Birmingham	Phase 1 / Phase 2
Completed	Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients NCT03222258	Seoul National University Hospital	—
Unknown	Pegteograstim in Children With Solid Tumors NCT02787876	Samsung Medical Center	Phase 2
Completed	A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors NCT02564198	Eli Lilly and Company	Phase 1
Active Not Recruiting	The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study NCT02520713	Dana-Farber Cancer Institute	—
Unknown	Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation NCT02339753	The Korean Society of Pediatric Hematology Oncology	Phase 2
Completed	iCAT for Recurrent/Refractory/HR Solid Tumors NCT01853345	Dana-Farber Cancer Institute	—